Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RABEPRAZOLE Cause Poor quality product administered? 6 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Poor quality product administered have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.1% of all adverse event reports for RABEPRAZOLE.

6
Reports of Poor quality product administered with RABEPRAZOLE
0.1%
of all RABEPRAZOLE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Poor quality product administered From RABEPRAZOLE?

Of the 6 reports.

Is Poor quality product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does RABEPRAZOLE Cause?

Chronic kidney disease (4,773) Renal failure (3,135) Acute kidney injury (2,545) End stage renal disease (1,295) Tubulointerstitial nephritis (1,125) Death (857) Drug ineffective (732) Dyspnoea (423) Gastrooesophageal reflux disease (416) Headache (387)

What Other Drugs Cause Poor quality product administered?

ONABOTULINUMTOXINA (495) ICOSAPENT ETHYL (452) MINOXIDIL (428) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (376) ADALIMUMAB (239) TESTOSTERONE CYPIONATE (235) SOMATROPIN (234) POLYETHYLENE GLYCOL 3350 (223) IBUPROFEN (222) INSULIN GLARGINE (133)

Which RABEPRAZOLE Alternatives Have Lower Poor quality product administered Risk?

RABEPRAZOLE vs RACECADOTRIL RABEPRAZOLE vs RADIATION THERAPY RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE RABEPRAZOLE vs RALOXIFENE RABEPRAZOLE vs RALTEGRAVIR

Related Pages

RABEPRAZOLE Full Profile All Poor quality product administered Reports All Drugs Causing Poor quality product administered RABEPRAZOLE Demographics